In the STEP trials, adults taking semaglutide experienced significant weight loss compared with placebo
However, since Saxenda (liraglutide) became the first GLP-1 approved for weight loss in 2014, additional options like Wegovy (semaglutide) and Zepbound (tirzepatide) have also been approved for weight management
2023 Aug 18:14:1205545
FDA "Compounding and the FDA: Questions and Answers" (regulatory status of compounded medications): fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers New England Journal of Medicine STEP 1 (Wilding et al., 2021)
For example, when a doctor prescribes Wegovy, Novos co-pay card program will guide the patient through assistance
When a cardiologist's primary clinical mandate is preventing heart attacks and strokes, and a drug demonstrates 20% reduction in major cardiovascular events, that drug becomes a cardiovascular medicine rather than a metabolic medicine